A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity.

Marc VasseBenjamin ZuberLaurie GoubeauMarie-Christine BallesterMathilde RoumierFrédérique DelcominetteFlorence HabarouEmilie JollyFelix AckermannCharles CerfEric FarfourTiffany Pascreaunull null

Published in: Clinical chemistry and laboratory medicine (2021)

Quantification of CD16pos monocytes and the ratio [absolute neutrophil count/CD16pos monocyte count] could constitute a marker of the severity of disease in COVID-19 patients.

Keyphrases

sars cov
peripheral blood
dendritic cells
nk cells
endothelial cells
immune response